When dichotomized, SSTR2 IHC was regarded as positive in 8 anaplastic gliomas and 1 GBMO (32%) and as negative in 6 anaplastic gliomas and 13 glioblastomas (GBMs) (68%). This evidence concerns the gene SSTR2 and glioblastoma.